| A1/A2A | Adenosine receptor type 1/type 2A |
| α1b | α1b adrenergic receptor |
| AT1/AT2 | Angiotensin II receptor type 1/type 2 |
| β2AR | β2 Adrenergic receptor |
| BiFC | Bimolecular fluorescence complementation assay |
| BiLC | Bimolecular luminescence complementation assay |
| BRET | Bioluminescence resonance energy transfer |
| CAD | Cath.-a-differentiated |
| cAMP | Cyclic adenosine monophosphate |
| CB1 | Cannabinoid receptor 1 |
| CC | C-terminal fragment of split Cerulean |
| CFP | Cerulean fluorescent protein |
| CC2 | C-C chemokine receptor type 2 |
| CFLuc | C-terminal fragment of split Firefly luciferase |
| CGFP | C-terminal fragment of split green fluorescent protein |
| CID | Chemically induced dimerization |
| CN | N-terminal fragment of split Cerulean |
| CODA-RET | Complemented donor–acceptor resonance energy transfer |
| co-IP | Co-immunoprecipitation |
| CPA | N6-cyclopentyladenosine |
| CXCR4/CXCR7 | C-X-C chemokine receptor type 4/type 7 |
| D1R/D2R/D3R | Dopamine receptor type 1/type 2/type 3 |
| D2LR | Dopamine receptor type 2 long isoform |
| D2SR | Dopamine receptor type 2 short isoform |
| DsRed | Discosoma Red |
| ECL | Extracellular loop |
| EGFP | Enhanced green fluorescent protein |
| FLuc | Firefly Luciferase |
| FFAR2/3 | Free fatty acid receptor type 2/type 3 |
| FRB | FKBP-rapamycin binding domain of mTOR |
| FKBP12 | FK506- and rapamycin-binding protein |
| FRET | Förster resonance energy transfer |
| GHSR1a | Growth hormone secretagogue receptor 1α |
| GLuc | Gaussia princeps luciferase |
| GPCR | G protein-coupled receptor |
| GRK | G protein-coupled receptor kinase |
| HEK | Human embryonic kidney |
| Homo-FC | Homo-molecular fluorescence complementation |
| 5-HTR | 5-hydroxytryptamine receptor |
| HTS | High-throughput screening |
| L-DOPA | L-3,4-dihydroxyphenylalanine |
| LcBiT | C-terminal fragment of split large BiT |
| LgBiT | Large BiT, large subunit of Nanoluciferase |
| LnBiT | N-terminal fragment of split large BiT |
| M1/M2/M4 | Muscarinic acetylcholine receptor type 1/type 2/type 4 |
| MAPK | Mitogen activated protein kinase |
| MBiFC | Multicolor Bimolecular fluorescence complementation assay |
| MC4R | Melanocortin 4 receptor |
| MOP | Mu-opioid receptor |
| MRAP2 | Melanocortin 2 receptor accessory protein 2 |
| α-MSH | α-Melanocyte- stimulating hormone |
| mGluR2/mGLuR5/mGluR6 | Metabotropic glutamate receptor type 2/type 5/type 6 |
| mRFP | Monomer red fluorescent protein |
| NanoBiT® | NanoLuc Binary Technology® |
| NFLuc | N-terminal fragment of split Firefly luciferase |
| NGFP | N-terminal fragment of split green fluorescent protein |
| NPFF2 | Neuropeptide FF receptor 2 |
| NPY | Neuropeptide Y |
| OX1R | Orexin 1 receptor |
| PCA | Protein complementation assay |
| PLA | Proximity ligation assay |
| PPI | Protein–protein interaction |
| P2RY1 | P2Y purinoceptor 1 |
| RLuc | Renilla Luciferase |
| SDS-PAGE | Sodium dodecyl sulfate–polyacrylamide gel electrophoresis |
| SH3 | SRC Homology 3 Domain |
| SmBiT | Small BiT, small subunit of Nanoluciferase |
| SpIDA | Spatial intensity distribution analysis |
| SRET | Sequential resonance energy transfer |
| TAT | Transactivator of transcription |
| TM | Transmembrane |
| TSHr | Thyrotropin receptor |
| VC | C-terminal fragment of split Venus |
| VN | N-terminal fragment of split Venus |
| YC | C-terminal fragment of split yellow fluorescent protein |
| YFP | Yellow fluorescent protein |
| YN | N-terminal fragment of split yellow fluorescent protein |